Submitted by Anonymous (not verified) on 7 January 2026 - 15:45
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 46, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 46, Status: Authorised